×

Our award-winning reporting has moved

Context provides news and analysis on three of the world’s most critical issues:

climate change, the impact of technology on society, and inclusive economies.

Nipah virus death toll rises to 15, two new cases found in India's Kerala

by Reuters
Thursday, 31 May 2018 15:57 GMT

Doctors and relatives wearing protective gear dig a grave to bury a victim of the brain-damaging Nipah virus in Kozhikode, Kerala, India, May 24, 2018. REUTERS/Stringer

Image Caption and Rights Information

There is no vaccine for the virus which is spread through bodily fluids and can cause encephalitis

(Updates with WHO comment)

By D. Jose and Subrat Patnaik

KOCHI/MUMBAI, May 31 (Reuters) - Two new cases of the deadly brain-damaging Nipah virus have been confirmed in the southern Indian state of Kerala, where another two people were killed by the virus, a health official said on Thursday.

The two new Nipah cases in Kerala take the total number of confirmed cases to 17, Kozhikode district medical officer V. Jayashree told Reuters. Fifteen of those people have died, she said.

The latest victims, identified as Madhusudhanan, 55, and Akhil, 28, were believed to have contracted the virus from a medical college, Jayashree said.

No confirmed cases of the virus have been found yet outside Kerala despite fears it had spread. Several other Indian states have sent samples for testing from people who reported Nipah-like symptoms in the past few days.

Samples taken from bats in Kozhikode district, the suspected epicentre of the infection, have been sent for testing to the National Institute of High Security Animal Diseases in Bhopal, Madhya Pradesh, animal husbandry officer A. Mohandas said, as officials continue to try to track the root of the outbreak.

There is no vaccine for the virus, which is spread through bodily fluids and can cause encephalitis, or inflammation of the brain, the World Health Organization says.

However, WHO said India has the capacity to rapidly respond and verify cases with laboratory testing.

"At the moment, the outbreak is localized and WHO assesses the risk to be low at the national and regional levels."

(Reporting by D. Jose in Kochi and Subrat Patnaik in Mumbai Editing by Euan Rocha and Paul Tait)

Our Standards: The Thomson Reuters Trust Principles.

-->